Clinical Trial Detail

NCT ID NCT03893682
Title A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Aptose Biosciences Inc.
Indications

chronic lymphocytic leukemia

CLL/SLL

non-Hodgkin lymphoma

Therapies

CG-806

Age Groups: senior adult

No variant requirements are available.